Physician Acceptance Rate of Pharmacist Recommendations to Reduce Use of Potentially Inappropriate Medications in the Assisted Living Setting

Consultant Pharmacist

Volumn 18, Issue 3, 2003, Pages 241-247

  Rhoads, Mark ^a   Thai, Amy ^b  

^a SunScript Pharmacy   (United States)

^b Safeway Inc   (United States)

Author keywords

Assisted living facilities; Beers' criteria; Consultant pharmacist; Drug regimen review; Inappropriate medication; Pharmacist interventions; Pharmacist recommendations

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ATROPINE; BARBITURIC ACID DERIVATIVE; BELLADONNA ALKALOID; BENZATROPINE; CHLORDIAZEPOXIDE; CHLORPHENIRAMINE; CHLORPROPAMIDE; CHLORZOXAZONE; CLONAZEPAM; DIAZEPAM; DICYCLOVERINE; DIGOXIN; DIPHENOXYLATE; DIPYRIDAMOLE; DOXEPIN; DRUG; FLURAZEPAM; HYDROXYZINE; LORAZEPAM; MEPROBAMATE; METHYLDOPA; PENTAZOCINE; PETHIDINE; RESERPINE; TEMAZEPAM; TICLOPIDINE; UNINDEXED DRUG; ZOLPIDEM;

AGED; ARTICLE; CONSULTATION; DRUG SAFETY; DRUG USE; ELDERLY CARE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACEUTICAL CARE; PHARMACIST; PHYSICIAN ATTITUDE; SIDE EFFECT; TREATMENT INDICATION;

EID: 0842321949     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Besdine RW, Beers MH, Bootman JL et al. When medication hurts instead of helps: preventing medication problems in older persons. Washington, DC: Alliance for Aging Research; 1998. pp. 1-12.
2. Beers MH, Ouslander JG, Rollingher I et al. Explicit criteria for determining potentially inappropriate medication use in nursing home residents. Arch Intern Med 1991;151:1825-32.
3. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 1997;157:1531-6.
4. http://www.ahcpr.gov/research/sep01/901RA4.htm, accessed August 7, 2002.
5. Zhan C, Sangl J, Bierman AS et al. Potentially inappropriate medication use in the community-dwelling elderly. JAMA 2001;286:2823-9.
6. Rhoads M, Thai A. Potentially inappropriate medications ordered for elderly residents of assisted living homes and assisted living centers. Consult Pharm 2002;17:572-8.
7. Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000;34:338-45.
8. Leape L, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
9. Gandhi PJ, Smith BS, Tataronis GR, Maas B. Impact of a pharmacist on drug costs in a coronary care unit. Am J Health-Syst Pharm 2001;58:497-501.
10. Monane M, Mathias DM, Nagle BA, Kelly MA. Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and the computer. JAMA 1998;280:1249-52.
11. Cooper J. Consultant pharmacist assessment and reduction of fall risk in nursing facilities. Consult Pharm 1997;12:1294-304.
12. Douzjian M, Wilson C, Shultz M et al. A program to use pain control medication to reduce psychotropic drug use in residents with difficult behavior. Ann LongTerm Care 1998;6:174-8.
13. Barber A, Hollenack K, Bottorff M. Congestive heart failure: a disease management approach in long-term care patients. J Managed Care Pharm; 1999;5:516-20.
14. Johnston AM, Doane K, Phipps S, Bell A. Outcomes of pharmacists' cognitive services in the long-term care setting. Consult Pharm 1996;11:41-50.
15. Blumi BM. Pharmaceutical care services and results in Project ImPACT: hyperlipidemia. J Am Pharm Assoc 2000;40:157-65.
16. http://www.accu-chekmanagedcare. com/cbp/cbpdiseasemanagement9.asp, accessed August 16, 2002.
17. Semla TP, Beizer JL, Higbee MD. Geriatric dosage handbook. 6th edition. Hudson, OH: Lexi-Comp Inc; 2000.